GSA Capital Partners’s Moderna MRNA Stock Holding History

GSA Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.49M	Buy	29,238 +3,664	+14%	+$171K	0.09%	288
2025 Q4	$754K	Sell	25,574 -13,348	-34%	-$363K	0.07%	540
2025 Q3	$1M	Buy	38,922 +26,617	+216%	+$742K	0.08%	392
2025 Q2	$339K	Buy	+12,305	New	+$324K	0.02%	1183
2025 Q1	–	Sell	-5,944	Closed	-$247K	–	1925
2024 Q4	$247K	Buy	5,944 +302	+5%	+$14.4K	0.02%	1316
2024 Q3	$377K	Buy	+5,642	New	+$518K	0.03%	1108
2024 Q1	–	Sell	-2,703	Closed	-$269K	–	1840
2023 Q4	$269K	Buy	+2,703	New	+$227K	0.02%	1172
2022 Q4	–	Sell	-2,149	Closed	-$254K	–	1731
2022 Q3	$254K	Buy	+2,149	New	+$326K	0.03%	1041
2022 Q2	–	Sell	-1,868	Closed	-$322K	–	1658
2022 Q1	$322K	Buy	+1,868	New	+$314K	0.04%	843
2021 Q2	–	Sell	-3,078	Closed	-$403K	–	1502
2021 Q1	$403K	Sell	3,078 -1,609	-34%	-$233K	0.07%	468
2020 Q4	$490K	Buy	+4,687	New	+$474K	0.08%	436
2019 Q3	–	Sell	-18,062	Closed	-$264K	–	1591
2019 Q2	$264K	Buy	+18,062	New	+$388K	0.03%	1084

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return